Narine Jeenarine

Avg. Two Year Performance

No purchase track record

(44%) Avg. Sale Return

(20%) Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	20%	(5%)	(4%)	12%	(44%)
Sale Success Rate	4 of 8	4 of 8	4 of 8	3 of 8	2 of 8

Elite Pharmaceuticals Inc.

Drugs » Drug Manufacturers - Other

:

Holdings: 16.74M shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--